CBO & COO of Crispr Therapeutics Ag (30-Year Financial, Insider Trades) Lawrence Otto Klein (insider trades) sold 70,000 shares of CRSP on 06/25/2020 at an average price of $75.88 a share. The total sale was $5.3 million.

CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics. CRISPR Therapeutics AG has a market cap of $4.76 billion; its shares were traded at around $74.04 with a P/E ratio of 98.71 and P/S ratio of 15.35. GuruFocus has detected 2 severe warning signs with CRISPR Therapeutics AG. .

CEO Recent Trades:

  • CEO Samarth Kulkarni sold 17,275 shares of CRSP stock on 06/01/2020 at the average price of $64.68. The price of the stock has increased by 14.47% since.

Directors and Officers Recent Trades:

  • CBO & COO Lawrence Otto Klein sold 70,000 shares of CRSP stock on 06/25/2020 at the average price of $75.88. The price of the stock has decreased by 2.42% since.
  • Executive VP, Head of R&D Tony W Ho sold 7,158 shares of CRSP stock on 06/23/2020 at the average price of $75.04. The price of the stock has decreased by 1.33% since.
  • Director Bradley J Phd Bolzon sold 20,000 shares of CRSP stock on 06/23/2020 at the average price of $73.93. The price of the stock has increased by 0.15% since.
  • President Rodger Novak sold 50,000 shares of CRSP stock on 06/23/2020 at the average price of $75. The price of the stock has decreased by 1.28% since.

For the complete insider trading history of CRSP, click here

.

Comments

Please leave your comment:



Source link